New ultrasound agent matches nuclear medicine
This article was originally published in Clinica
Executive Summary
Preclinical studies show that Acusphere's new ultrasound contrast agent has the potential to simplify contrast echocardiography because it can be detected continuously after bolus administration. Trials of AI-700 in dogs show that gas-filled synthetic polymer microspheres detect areas of low blood flow in the heart muscle, in high agreement with nuclear medicine, the current gold standard for detecting heart prefusion defects, say cardiologists at Tufts-New England Medical Center in Boston.